Intact Vascular Announces $20 Million Series C Financing to Fund Company through PMA Approval of the Tack Endovascular System® WAYNE, Pa., April 16, 2018-- Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today announced that it closed a Series C financing totaling $20 million. This financing is designed to fund the Company through Pre-Market Approval (“PMA”) of the Tack Endovascular System for the treatment of post-angioplasty dissections above the knee. Major participants in the Series C financing included New Enterprise Associates (“NEA”), H.I.G. BioVentures and Quaker Partners.